Benoit Delatour

Title: Benoit Delatour: Innovator in Antibody Research

Introduction

Benoit Delatour is a prominent inventor based in Cachan, France. He has made significant contributions to the field of antibody research, particularly in the development of innovative therapeutic solutions. With a total of 5 patents to his name, Delatour's work focuses on addressing complex neurological disorders.

Latest Patents

One of his latest patents is titled "Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof." This invention relates to variable domains of camelid heavy-chain antibodies that target phosphorylated tau proteins. The conjugates developed from this invention are intended for the treatment or diagnosis of disorders associated with neurofibrillary tangles, neuropil threads, or dystrophic neurites, such as tauopathies. Another notable patent is for an "Oligopeptide and methods for producing conjugates thereof." This invention involves oligopeptides and their conjugates, which are useful for treating or diagnosing disorders linked to amyloid β deposits. Additionally, it includes a coupling method for obtaining functional conjugates.

Career Highlights

Throughout his career, Benoit Delatour has worked with esteemed organizations such as F. Hoffmann-La Roche AG and Institut Pasteur. His experience in these institutions has allowed him to refine his expertise in antibody research and contribute to groundbreaking innovations in the field.

Collaborations

Delatour has collaborated with notable colleagues, including Pierre Lafaye and Sylvie Bay. These partnerships have further enhanced his research and development efforts, leading to significant advancements in therapeutic applications.

Conclusion

Benoit Delatour's innovative work in antibody research has positioned him as a key figure in the scientific community. His patents reflect a commitment to addressing critical health challenges through advanced therapeutic solutions.